Medivate Partners LLC

Investor type

VC

Founded

2012

AUM

$80 M

Location

South Korea

$10-50 m

Investment Ticket

3-5 years

Investment Horizon

Series B

Investment Stage

Sale to strategic investor, IPO

Exit Strategy

Profile

Founded in 2012, Medivate is one of the first private equity firms in Korea with the expertise in value investing cross-border life sciences industry. Medivate has been raised ~$80 million capital into 5 portfolio companies which include clinical stage biotech companies and contract development manufacturing organizations (CDMOs). Medivate’s management team has proven record in life sciences industry provides competitive advantage by leveraging strategic partnership with the portfolio companies, a key to the successful investment returns.

Industry

Healthcare Services Biotechnology Medical Devices Pharmaceuticals MedTech Life Sciences

Region of investment

Asia

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
0ev9MbhuEi4nLBCV Senior Principal
Senior Principal
avatar
0ev9MbhuEi4nLBCV CEO & Managing Partner
CEO & Managing Partner
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!